Experimental Antibody Treatment Is At The Ready For Americans Exposed To Ebola

Experimental Antibody Treatment Is At The Ready For Americans Exposed To Ebola The Biomedical Advanced Research and Development Authority is coordinating a shipment of monoclonal antibodies “for potential use in high-risk Americans exposed to the virus,” an HHS spokesperson revealed. MBP-134 would be used under the FDA’s “investigational use mechanisms,” a measure that allows unlicensed treatments to be used in emergency situations, Stat reports. https://kffhealthnews.org/morning-breakout/outbreaks-and-health-threats-060526/